End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
89,500 KRW | +0.79% | +2.17% | -10.86% |
01-30 | SK Biopharmaceuticals Swings to Profit in Q4 | MT |
2023 | SK Group Advances Net Zero Transition via Key Renewable Energy Deal | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.86% | 5.14B | |
+6.80% | 72.03B | |
+46.43% | 4.6B | |
+5.38% | 3.96B | |
-16.20% | 2.5B | |
+21.27% | 2.43B | |
-26.20% | 2.32B | |
+19.92% | 2.18B | |
+8.15% | 1.72B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- A326030 Stock
- News SK Biopharmaceuticals Co., Ltd.
- SK Biopharmaceuticals Forecasts $1 Billion in US Sales by 2029